Trials / Withdrawn
WithdrawnNCT03078725
Failure Rate of GLyburide And Metformin Among Gestational Diabetics
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
A pragmatic, comparative effectiveness trial of glyburide versus metformin.
Detailed description
Patients with gestational diabetes requiring pharmaceutical treatment will be randomized to receive glyburide or metformin. Dose increases will be determined by the patient's physician. Patients will be determined to have failed either medication if glucose control can not be achieved with the maximum dose of the medication, if insulin is stared to achieve glucose control or if another oral agent is started along for glucose control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glyburide | oral hypoglycemic agent |
| DRUG | Metformin | oral hypoglycemic agent |
Timeline
- Start date
- 2017-06-20
- Primary completion
- 2018-03-10
- Completion
- 2018-05-10
- First posted
- 2017-03-13
- Last updated
- 2018-05-04
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03078725. Inclusion in this directory is not an endorsement.